Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005787 · ClinicalTrials.gov registry record · Phase 1
Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
A Phase 1 study, sponsored by Northwestern University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT00005787: Clinical Trial Phase 1 study, sponsored by Northwestern University.
NCT00005787 is a Phase 1 study that was terminated before completion, run by Northwestern University. The registered enrollment target is 3 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005787, a Phase 1 study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy used to kill cancer cells. Treating the peripheral stem cells in the laboratory may improve the effectiveness of the transplant. PURPOSE: Phase I trial to study the effectiveness of peripheral stem cell transplantation in patients who have relapsed or refractory non-Hodgkin's lymphoma and who will be treated with high-dose chemotherapy.
Interventions
- BIOLOGICAL filgrastim
- BIOLOGICAL epoetin alfa
- BIOLOGICAL sargramostim
- BIOLOGICAL recombinant flt3 ligand
- BIOLOGICAL recombinant interleukin-3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 1999-09 |
| Est. Completion | 2002-01 |
| Phase | Phase 1 |
Why NCT00005787 stopped before completion
NCT00005787 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 5 interventions - of which filgrastim is the first listed.
NCT00005787 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00005787 about?
NCT00005787 is a clinical study titled "Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma". RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy used to kill cancer cells. Treating the peripheral stem cells in the laboratory may improve the effectiveness of the transplant. PURPOSE: Phase I trial to study the effectiveness ...
What is the current status of trial NCT00005787?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 1999-09. Estimated completion is 2002-01.
What interventions are being tested in trial NCT00005787?
The interventions under investigation include: filgrastim (BIOLOGICAL), epoetin alfa (BIOLOGICAL), sargramostim (BIOLOGICAL), recombinant flt3 ligand (BIOLOGICAL), recombinant interleukin-3 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00005787?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00005787's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia